On September 3, 2019 Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") reported that Company management will participate at the following upcoming investment conferences in September (Press release, Intech Pharmaceuticals, SEP 3, 2019, https://www.prnewswire.com/news-releases/intec-pharma-to-participate-in-september-investment-conferences-300910451.html [SID1234539225]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

HC Wainwright 21st Annual Global Investment Conference
Date: September 8-10, 2019
Company Presentation: Monday, September 9, 2019 at 4:40 pm (Eastern time)

Location: Lotte New York Palace Hotel, New York City
Presenter: Jeffrey A. Meckler, Vice Chairman and Chief Executive Officer of Intec Pharma
Format: Corporate presentation and One-on-One Investor Meetings

Ladenburg Thalmann 2019 Healthcare Conference
Date: September 24, 2019

Company Presentation: September 24, 2019 at 11:30 am (Eastern time)
Location: Sofitel, New York City
Presenter: Walt Linscott, Chief Business Officer
Format: Corporate presentation and One-on-One Investor Meetings

Both presentations will be webcast live and will be accessible through the Events section of Intec Pharma’s website at www.intecpharma.com, where they will also be archived for a period of time.